Business registries · firm from USPTO records
Dynavax Technologies Corporation
- Place
- 2929 Seventh Street, Suite 100, Berkeley, CA
- Entity type
- Corporation
- State of organization
- DE (as the owner states it in trademark filings)
- Patents
- 48 granted 2002-11-21 to 2025-08-05
- Trademarks
- 33, 15 live
- Record
- FUZZY low confidence: same name (legal endings aside), one of each nationally
- SEC filer
- DYNAVAX TECHNOLOGIES CORP FUZZY low confidence: same name (legal endings aside), one of each nationally
- Source
- USPTO: PVGPATDIS and TRCFECO2 (PVGPATDIS file of 2026-04-10, TRCFECO2 file of 2024-03-27); patent assignee and trademark owner with the same name (legal endings aside) and place
Patents
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12605442 | Production of vaccines comprising inactivated SARS-CoV-2 viral particles | 2026-04-21 | PTBLXML, file of 2026-04-21 |
| US 12569553 | Shingles vaccines comprising a TLR9 agonist | 2026-03-10 | PTBLXML, file of 2026-03-10 |
| US 12378255 | Toll-like receptor antagonist compounds and methods of use | 2025-08-05 | PVGPATDIS, file of 2026-04-10 |
| US 12364745 | Immunogenicity of a CpG-adjuvanted recombinant plague vaccine | 2025-07-22 | PVGPATDIS, file of 2026-04-10 |
| US 12296002 | Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) | 2025-05-13 | PVGPATDIS, file of 2026-04-10 |
| US 11981670 | Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof | 2024-05-14 | PVGPATDIS, file of 2026-04-10 |
| US 11827641 | Toll-like receptor antagonist compounds and methods of use | 2023-11-28 | PVGPATDIS, file of 2026-04-10 |
| US 11684669 | CpG-adjuvanted SARS-CoV-2 virus vaccine | 2023-06-27 | PVGPATDIS, file of 2026-04-10 |
| US 11370794 | Toll-like receptor antagonist compounds and methods of use | 2022-06-28 | PVGPATDIS, file of 2026-04-10 |
| US 11124510 | Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof | 2021-09-21 | PVGPATDIS, file of 2026-04-10 |
| US 10751412 | Combination of a PD-1 antagonist and CPG-C type oligonucleotide for treating cancer | 2020-08-25 | PVGPATDIS, file of 2026-04-10 |
| US 10722591 | Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereof | 2020-07-28 | PVGPATDIS, file of 2026-04-10 |
| US 10618896 | Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereof | 2020-04-14 | PVGPATDIS, file of 2026-04-10 |
| US 10548975 | Branched chimeric compounds, and methods of use thereof | 2020-02-04 | PVGPATDIS, file of 2026-04-10 |
| US 10369168 | Administration of polynucleotide toll-like receptor 9 agonists for treating cancer | 2019-08-06 | PVGPATDIS, file of 2026-04-10 |
| US 10350290 | Linear chimeric compounds and methods of use thereof | 2019-07-16 | PVGPATDIS, file of 2026-04-10 |
| US 10314907 | Methods and compositions for eliciting an immune response against hepatitis B virus | 2019-06-11 | PVGPATDIS, file of 2026-04-10 |
| US 10196643 | Immunostimulatory sequence oligonucleotides and methods of using the same | 2019-02-05 | PVGPATDIS, file of 2026-04-10 |
| US 10111899 | Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung | 2018-10-30 | PVGPATDIS, file of 2026-04-10 |
| US 9993495 | Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lung | 2018-06-12 | PVGPATDIS, file of 2026-04-10 |
| US 9950064 | Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof | 2018-04-24 | PVGPATDIS, file of 2026-04-10 |
| US 9884110 | Methods and compositions for eliciting an immune response against hepatitis B virus | 2018-02-06 | PVGPATDIS, file of 2026-04-10 |
| US 9868955 | Human toll-like receptor inhibitors and methods of use thereof | 2018-01-16 | PVGPATDIS, file of 2026-04-10 |
| US 9476053 | Methods and compositions for inhibition of immune responses and autoimmunity | 2016-10-25 | PVGPATDIS, file of 2026-04-10 |
| US 9452212 | Methods and compositions for eliciting an immune response against hepatitis B virus | 2016-09-27 | PVGPATDIS, file of 2026-04-10 |
The newest 25 of 48. All patents of this assignee
Trademarks
| Mark | Serial | Filed | Status | Classes | Source |
|---|---|---|---|---|---|
| HEPLISAV-B | 98014169 | 2023-05-25 | Registered | 044 | TRTYRAP, file of 2026-04-03 |
| HEPLISAV-B | 98014166 | 2023-05-25 | Registered | 005 | TRTYRAP, file of 2026-04-03 |
| HEPLISAV-B | 98014161 | 2023-05-25 | Registered | 044 | TRTYRAP, file of 2026-04-03 |
| DYNAVAX | 97518587 | 2022-07-25 | Registered | 044 | TRTYRAP, file of 2026-04-03 |
| DYNAVAX | 97518585 | 2022-07-25 | Registered | 042 | TRTYRAP, file of 2026-04-03 |
| DYNAVAX | 97518582 | 2022-07-25 | Registered | 005 | TRCFECO2, file of 2024-03-27 |
| DYNAVAX | 97518579 | 2022-07-25 | Registered | 044 | TRTYRAP, file of 2026-04-03 |
| PROTECTION FOR AN UNPREDICTABLE WORLD | 88912346 | 2020-05-12 | Registered | 042 | TRTDXFAP, file of 2025-12-10 |
| CPG 1018 | 88822935 | 2020-03-05 | Registered | 005 | TRTDXFAP, file of 2026-07-21 |
| HEPLISAV-B ACCESS NAVIGATOR | 87872023 | 2018-04-11 | Registered | 036 | TRTYRAP, file of 2026-04-03 |
| DYNAVAX ACCESS NAVIGATOR | 87872022 | 2018-04-11 | Abandoned | 036 | TRCFECO2, file of 2024-03-27 |
| ACCESS NAVIGATOR | 87872021 | 2018-04-11 | Registered | 036 | TRTYRAP, file of 2026-04-03 |
| HEPLISAV-B | 87145972 | 2016-08-22 | Registered | 005 | TRCFECO2, file of 2024-03-27 |
| DYNAVAX INNOVATING IMMUNOLOGY | 86489837 | 2014-12-23 | Registration cancelled | 042 | TRCFECO2, file of 2024-03-27 |
| DYNAVAX INNOVATING IMMUNOLOGY | 86489831 | 2014-12-23 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| HEPLISAV-B | 85840674 | 2013-02-05 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| ZELIVAX | 85522423 | 2012-01-23 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| EXTEBA | 85522418 | 2012-01-23 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| XTEBA | 85522416 | 2012-01-23 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| PREBEVAX | 85522415 | 2012-01-23 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| EXIVAX | 85192980 | 2010-12-08 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| BEKOYA | 85192976 | 2010-12-08 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| VAXXAV | 85192973 | 2010-12-08 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| HEPLIVAX | 85192966 | 2010-12-08 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
| HEBNEX | 85119136 | 2010-08-30 | Abandoned | 005 | TRCFECO2, file of 2024-03-27 |
The newest 25 of 33. All marks of this owner
Possible related entities
No other firm on file at the same street address.
Firms here are built from USPTO patent assignees (PatentsView) and trademark owners: one firm per name (legal endings aside) and state, or country outside the US. Matches to other records are by name and state: EXACT means the identical full name, FUZZY a looser match, with the confidence shown.